nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Vismodegib—skin cancer	0.12	0.146	CbGbCtD
Loratadine—CYP2C19—Vismodegib—skin cancer	0.101	0.122	CbGbCtD
Loratadine—CYP2C9—Vismodegib—skin cancer	0.084	0.102	CbGbCtD
Loratadine—ABCB1—Vismodegib—skin cancer	0.0815	0.0986	CbGbCtD
Loratadine—CYP3A4—Imiquimod—skin cancer	0.0705	0.0852	CbGbCtD
Loratadine—CYP3A4—Temozolomide—skin cancer	0.0705	0.0852	CbGbCtD
Loratadine—CYP2D6—Vemurafenib—skin cancer	0.0607	0.0734	CbGbCtD
Loratadine—CYP3A4—Vismodegib—skin cancer	0.0488	0.0591	CbGbCtD
Loratadine—ABCB1—Dactinomycin—skin cancer	0.0428	0.0518	CbGbCtD
Loratadine—CYP2C8—Fluorouracil—skin cancer	0.0428	0.0517	CbGbCtD
Loratadine—CYP3A4—Vemurafenib—skin cancer	0.0386	0.0467	CbGbCtD
Loratadine—CYP2C9—Fluorouracil—skin cancer	0.0298	0.0361	CbGbCtD
Loratadine—ABCB1—Docetaxel—skin cancer	0.0221	0.0267	CbGbCtD
Loratadine—CYP3A4—Docetaxel—skin cancer	0.0132	0.016	CbGbCtD
Loratadine—Abdominal pain upper—Vismodegib—skin cancer	0.00305	0.0176	CcSEcCtD
Loratadine—Cardiovascular disorder—Imiquimod—skin cancer	0.00276	0.0159	CcSEcCtD
Loratadine—Viral infection—Imiquimod—skin cancer	0.00269	0.0155	CcSEcCtD
Loratadine—Alopecia—Vismodegib—skin cancer	0.00204	0.0118	CcSEcCtD
Loratadine—Dysgeusia—Vismodegib—skin cancer	0.00197	0.0114	CcSEcCtD
Loratadine—Blister—Fluorouracil—skin cancer	0.00186	0.0107	CcSEcCtD
Loratadine—Lethargy—Imiquimod—skin cancer	0.0018	0.0104	CcSEcCtD
Loratadine—Myalgia—Vismodegib—skin cancer	0.00171	0.0099	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.0017	0.00983	CcSEcCtD
Loratadine—Nervous system disorder—Vismodegib—skin cancer	0.00161	0.00931	CcSEcCtD
Loratadine—Viral infection—Temozolomide—skin cancer	0.00161	0.0093	CcSEcCtD
Loratadine—Skin disorder—Vismodegib—skin cancer	0.0016	0.00922	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.0015	0.00865	CcSEcCtD
Loratadine—Dyspepsia—Vismodegib—skin cancer	0.00145	0.00835	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00142	0.00819	CcSEcCtD
Loratadine—Fatigue—Vismodegib—skin cancer	0.00142	0.00818	CcSEcCtD
Loratadine—Pain—Vismodegib—skin cancer	0.0014	0.00811	CcSEcCtD
Loratadine—Constipation—Vismodegib—skin cancer	0.0014	0.00811	CcSEcCtD
Loratadine—Depression—Imiquimod—skin cancer	0.00135	0.00782	CcSEcCtD
Loratadine—Gastrointestinal pain—Vismodegib—skin cancer	0.00134	0.00776	CcSEcCtD
Loratadine—Abdominal pain—Vismodegib—skin cancer	0.0013	0.0075	CcSEcCtD
Loratadine—Hepatobiliary disease—Imiquimod—skin cancer	0.00128	0.00741	CcSEcCtD
Loratadine—Alopecia—Vemurafenib—skin cancer	0.00126	0.00729	CcSEcCtD
Loratadine—Dysgeusia—Vemurafenib—skin cancer	0.00122	0.00703	CcSEcCtD
Loratadine—Pharyngitis—Imiquimod—skin cancer	0.00121	0.00698	CcSEcCtD
Loratadine—Lethargy—Dactinomycin—skin cancer	0.00119	0.00688	CcSEcCtD
Loratadine—Asthenia—Vismodegib—skin cancer	0.00118	0.00681	CcSEcCtD
Loratadine—Tinnitus—Imiquimod—skin cancer	0.00114	0.00656	CcSEcCtD
Loratadine—Diarrhoea—Vismodegib—skin cancer	0.00112	0.00649	CcSEcCtD
Loratadine—Immune system disorder—Imiquimod—skin cancer	0.0011	0.00636	CcSEcCtD
Loratadine—Arrhythmia—Imiquimod—skin cancer	0.00109	0.00629	CcSEcCtD
Loratadine—Cough—Vemurafenib—skin cancer	0.00109	0.00627	CcSEcCtD
Loratadine—Alopecia—Imiquimod—skin cancer	0.00108	0.00622	CcSEcCtD
Loratadine—Myalgia—Vemurafenib—skin cancer	0.00106	0.00612	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00105	0.00607	CcSEcCtD
Loratadine—Vomiting—Vismodegib—skin cancer	0.00104	0.00603	CcSEcCtD
Loratadine—Drug interaction—Docetaxel—skin cancer	0.00104	0.00602	CcSEcCtD
Loratadine—Rash—Vismodegib—skin cancer	0.00104	0.00598	CcSEcCtD
Loratadine—Dermatitis—Vismodegib—skin cancer	0.00103	0.00598	CcSEcCtD
Loratadine—Dermatitis bullous—Fluorouracil—skin cancer	0.00102	0.00588	CcSEcCtD
Loratadine—Anaphylactic shock—Vemurafenib—skin cancer	0.00101	0.00586	CcSEcCtD
Loratadine—Nervous system disorder—Vemurafenib—skin cancer	0.000995	0.00575	CcSEcCtD
Loratadine—Lethargy—Fluorouracil—skin cancer	0.000992	0.00573	CcSEcCtD
Loratadine—Skin disorder—Vemurafenib—skin cancer	0.000986	0.00569	CcSEcCtD
Loratadine—Ill-defined disorder—Imiquimod—skin cancer	0.000984	0.00568	CcSEcCtD
Loratadine—Nausea—Vismodegib—skin cancer	0.000976	0.00564	CcSEcCtD
Loratadine—Agitation—Imiquimod—skin cancer	0.000975	0.00563	CcSEcCtD
Loratadine—Angioedema—Imiquimod—skin cancer	0.000969	0.0056	CcSEcCtD
Loratadine—Malaise—Imiquimod—skin cancer	0.000956	0.00552	CcSEcCtD
Loratadine—Syncope—Imiquimod—skin cancer	0.000951	0.00549	CcSEcCtD
Loratadine—Hypotension—Vemurafenib—skin cancer	0.000948	0.00548	CcSEcCtD
Loratadine—Palpitations—Imiquimod—skin cancer	0.000937	0.00541	CcSEcCtD
Loratadine—Loss of consciousness—Imiquimod—skin cancer	0.000932	0.00538	CcSEcCtD
Loratadine—Cough—Imiquimod—skin cancer	0.000925	0.00535	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000925	0.00534	CcSEcCtD
Loratadine—Hypertension—Imiquimod—skin cancer	0.000916	0.00529	CcSEcCtD
Loratadine—Chest pain—Imiquimod—skin cancer	0.000903	0.00522	CcSEcCtD
Loratadine—Myalgia—Imiquimod—skin cancer	0.000903	0.00522	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000897	0.00518	CcSEcCtD
Loratadine—Discomfort—Imiquimod—skin cancer	0.000892	0.00515	CcSEcCtD
Loratadine—Dry mouth—Imiquimod—skin cancer	0.000883	0.0051	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000876	0.00506	CcSEcCtD
Loratadine—Fatigue—Vemurafenib—skin cancer	0.000875	0.00505	CcSEcCtD
Loratadine—Constipation—Vemurafenib—skin cancer	0.000868	0.00501	CcSEcCtD
Loratadine—Shock—Imiquimod—skin cancer	0.000852	0.00492	CcSEcCtD
Loratadine—Nervous system disorder—Imiquimod—skin cancer	0.000849	0.0049	CcSEcCtD
Loratadine—Tachycardia—Imiquimod—skin cancer	0.000845	0.00488	CcSEcCtD
Loratadine—Pollakiuria—Temozolomide—skin cancer	0.000843	0.00487	CcSEcCtD
Loratadine—Skin disorder—Imiquimod—skin cancer	0.000841	0.00486	CcSEcCtD
Loratadine—Depression—Temozolomide—skin cancer	0.000811	0.00468	CcSEcCtD
Loratadine—Body temperature increased—Vemurafenib—skin cancer	0.000802	0.00463	CcSEcCtD
Loratadine—Pharyngitis—Dactinomycin—skin cancer	0.000801	0.00463	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000789	0.00456	CcSEcCtD
Loratadine—Insomnia—Imiquimod—skin cancer	0.000783	0.00452	CcSEcCtD
Loratadine—Paraesthesia—Imiquimod—skin cancer	0.000777	0.00449	CcSEcCtD
Loratadine—Somnolence—Imiquimod—skin cancer	0.000769	0.00444	CcSEcCtD
Loratadine—Hepatobiliary disease—Temozolomide—skin cancer	0.000769	0.00444	CcSEcCtD
Loratadine—Alopecia—Bleomycin—skin cancer	0.000765	0.00442	CcSEcCtD
Loratadine—Dyspepsia—Imiquimod—skin cancer	0.000762	0.0044	CcSEcCtD
Loratadine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000747	0.00432	CcSEcCtD
Loratadine—Fatigue—Imiquimod—skin cancer	0.000746	0.00431	CcSEcCtD
Loratadine—Pain—Imiquimod—skin cancer	0.00074	0.00428	CcSEcCtD
Loratadine—Dermatitis bullous—Docetaxel—skin cancer	0.000734	0.00424	CcSEcCtD
Loratadine—Asthenia—Vemurafenib—skin cancer	0.000728	0.00421	CcSEcCtD
Loratadine—Pharyngitis—Temozolomide—skin cancer	0.000725	0.00419	CcSEcCtD
Loratadine—Lethargy—Docetaxel—skin cancer	0.000716	0.00414	CcSEcCtD
Loratadine—Alopecia—Dactinomycin—skin cancer	0.000713	0.00412	CcSEcCtD
Loratadine—Feeling abnormal—Imiquimod—skin cancer	0.000713	0.00412	CcSEcCtD
Loratadine—Gastrointestinal pain—Imiquimod—skin cancer	0.000708	0.00409	CcSEcCtD
Loratadine—Epistaxis—Fluorouracil—skin cancer	0.000707	0.00408	CcSEcCtD
Loratadine—Ill-defined disorder—Bleomycin—skin cancer	0.000699	0.00404	CcSEcCtD
Loratadine—Diarrhoea—Vemurafenib—skin cancer	0.000694	0.00401	CcSEcCtD
Loratadine—Abdominal pain—Imiquimod—skin cancer	0.000684	0.00395	CcSEcCtD
Loratadine—Body temperature increased—Imiquimod—skin cancer	0.000684	0.00395	CcSEcCtD
Loratadine—Tinnitus—Temozolomide—skin cancer	0.000681	0.00393	CcSEcCtD
Loratadine—Malaise—Bleomycin—skin cancer	0.000679	0.00392	CcSEcCtD
Loratadine—Dizziness—Vemurafenib—skin cancer	0.000671	0.00388	CcSEcCtD
Loratadine—Pharyngitis—Fluorouracil—skin cancer	0.000668	0.00386	CcSEcCtD
Loratadine—Immune system disorder—Temozolomide—skin cancer	0.000659	0.00381	CcSEcCtD
Loratadine—Cough—Bleomycin—skin cancer	0.000657	0.0038	CcSEcCtD
Loratadine—Ill-defined disorder—Dactinomycin—skin cancer	0.000652	0.00377	CcSEcCtD
Loratadine—Vomiting—Vemurafenib—skin cancer	0.000645	0.00373	CcSEcCtD
Loratadine—Alopecia—Temozolomide—skin cancer	0.000645	0.00373	CcSEcCtD
Loratadine—Myalgia—Bleomycin—skin cancer	0.000641	0.00371	CcSEcCtD
Loratadine—Chest pain—Bleomycin—skin cancer	0.000641	0.00371	CcSEcCtD
Loratadine—Abdominal pain upper—Docetaxel—skin cancer	0.000641	0.0037	CcSEcCtD
Loratadine—Rash—Vemurafenib—skin cancer	0.00064	0.0037	CcSEcCtD
Loratadine—Dermatitis—Vemurafenib—skin cancer	0.000639	0.00369	CcSEcCtD
Loratadine—Headache—Vemurafenib—skin cancer	0.000636	0.00367	CcSEcCtD
Loratadine—Discomfort—Bleomycin—skin cancer	0.000634	0.00366	CcSEcCtD
Loratadine—Malaise—Dactinomycin—skin cancer	0.000634	0.00366	CcSEcCtD
Loratadine—Dysgeusia—Temozolomide—skin cancer	0.000622	0.0036	CcSEcCtD
Loratadine—Asthenia—Imiquimod—skin cancer	0.000621	0.00359	CcSEcCtD
Loratadine—Anaphylactic shock—Bleomycin—skin cancer	0.000615	0.00355	CcSEcCtD
Loratadine—Nausea—Vemurafenib—skin cancer	0.000603	0.00348	CcSEcCtD
Loratadine—Arrhythmia—Fluorouracil—skin cancer	0.000601	0.00347	CcSEcCtD
Loratadine—Myalgia—Dactinomycin—skin cancer	0.000598	0.00346	CcSEcCtD
Loratadine—Alopecia—Fluorouracil—skin cancer	0.000594	0.00343	CcSEcCtD
Loratadine—Diarrhoea—Imiquimod—skin cancer	0.000592	0.00342	CcSEcCtD
Loratadine—Discomfort—Dactinomycin—skin cancer	0.000591	0.00341	CcSEcCtD
Loratadine—Ill-defined disorder—Temozolomide—skin cancer	0.00059	0.00341	CcSEcCtD
Loratadine—Agitation—Temozolomide—skin cancer	0.000584	0.00337	CcSEcCtD
Loratadine—Angioedema—Temozolomide—skin cancer	0.000581	0.00335	CcSEcCtD
Loratadine—Hypotension—Bleomycin—skin cancer	0.000575	0.00332	CcSEcCtD
Loratadine—Malaise—Temozolomide—skin cancer	0.000573	0.00331	CcSEcCtD
Loratadine—Dizziness—Imiquimod—skin cancer	0.000572	0.00331	CcSEcCtD
Loratadine—Palpitations—Temozolomide—skin cancer	0.000562	0.00324	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00056	0.00324	CcSEcCtD
Loratadine—Cough—Temozolomide—skin cancer	0.000555	0.0032	CcSEcCtD
Loratadine—Paraesthesia—Bleomycin—skin cancer	0.000552	0.00319	CcSEcCtD
Loratadine—Vomiting—Imiquimod—skin cancer	0.00055	0.00318	CcSEcCtD
Loratadine—Hypertension—Temozolomide—skin cancer	0.000549	0.00317	CcSEcCtD
Loratadine—Rash—Imiquimod—skin cancer	0.000546	0.00315	CcSEcCtD
Loratadine—Dermatitis—Imiquimod—skin cancer	0.000545	0.00315	CcSEcCtD
Loratadine—Headache—Imiquimod—skin cancer	0.000542	0.00313	CcSEcCtD
Loratadine—Myalgia—Temozolomide—skin cancer	0.000541	0.00313	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000537	0.0031	CcSEcCtD
Loratadine—Discomfort—Temozolomide—skin cancer	0.000535	0.00309	CcSEcCtD
Loratadine—Dry mouth—Temozolomide—skin cancer	0.000529	0.00306	CcSEcCtD
Loratadine—Pain—Bleomycin—skin cancer	0.000526	0.00304	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000522	0.00302	CcSEcCtD
Loratadine—Anaphylactic shock—Temozolomide—skin cancer	0.000519	0.003	CcSEcCtD
Loratadine—Nausea—Imiquimod—skin cancer	0.000514	0.00297	CcSEcCtD
Loratadine—Hepatobiliary disease—Docetaxel—skin cancer	0.000511	0.00295	CcSEcCtD
Loratadine—Epistaxis—Docetaxel—skin cancer	0.00051	0.00295	CcSEcCtD
Loratadine—Nervous system disorder—Temozolomide—skin cancer	0.000509	0.00294	CcSEcCtD
Loratadine—Feeling abnormal—Bleomycin—skin cancer	0.000507	0.00293	CcSEcCtD
Loratadine—Skin disorder—Temozolomide—skin cancer	0.000504	0.00291	CcSEcCtD
Loratadine—Chest pain—Fluorouracil—skin cancer	0.000499	0.00288	CcSEcCtD
Loratadine—Myalgia—Fluorouracil—skin cancer	0.000499	0.00288	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—skin cancer	0.000494	0.00286	CcSEcCtD
Loratadine—Discomfort—Fluorouracil—skin cancer	0.000493	0.00285	CcSEcCtD
Loratadine—Pain—Dactinomycin—skin cancer	0.00049	0.00283	CcSEcCtD
Loratadine—Body temperature increased—Bleomycin—skin cancer	0.000486	0.00281	CcSEcCtD
Loratadine—Pharyngitis—Docetaxel—skin cancer	0.000482	0.00278	CcSEcCtD
Loratadine—Anaphylactic shock—Fluorouracil—skin cancer	0.000478	0.00276	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—skin cancer	0.000473	0.00273	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000473	0.00273	CcSEcCtD
Loratadine—Insomnia—Temozolomide—skin cancer	0.000469	0.00271	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000469	0.00271	CcSEcCtD
Loratadine—Nervous system disorder—Fluorouracil—skin cancer	0.000469	0.00271	CcSEcCtD
Loratadine—Tachycardia—Fluorouracil—skin cancer	0.000466	0.00269	CcSEcCtD
Loratadine—Paraesthesia—Temozolomide—skin cancer	0.000466	0.00269	CcSEcCtD
Loratadine—Somnolence—Temozolomide—skin cancer	0.000461	0.00266	CcSEcCtD
Loratadine—Dyspepsia—Temozolomide—skin cancer	0.000457	0.00264	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—skin cancer	0.000453	0.00262	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—skin cancer	0.000453	0.00262	CcSEcCtD
Loratadine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000448	0.00259	CcSEcCtD
Loratadine—Fatigue—Temozolomide—skin cancer	0.000447	0.00258	CcSEcCtD
Loratadine—Hypotension—Fluorouracil—skin cancer	0.000447	0.00258	CcSEcCtD
Loratadine—Pain—Temozolomide—skin cancer	0.000444	0.00256	CcSEcCtD
Loratadine—Constipation—Temozolomide—skin cancer	0.000444	0.00256	CcSEcCtD
Loratadine—Asthenia—Bleomycin—skin cancer	0.000441	0.00255	CcSEcCtD
Loratadine—Immune system disorder—Docetaxel—skin cancer	0.000439	0.00253	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000435	0.00252	CcSEcCtD
Loratadine—Arrhythmia—Docetaxel—skin cancer	0.000434	0.00251	CcSEcCtD
Loratadine—Insomnia—Fluorouracil—skin cancer	0.000432	0.0025	CcSEcCtD
Loratadine—Paraesthesia—Fluorouracil—skin cancer	0.000429	0.00248	CcSEcCtD
Loratadine—Alopecia—Docetaxel—skin cancer	0.000429	0.00248	CcSEcCtD
Loratadine—Feeling abnormal—Temozolomide—skin cancer	0.000427	0.00247	CcSEcCtD
Loratadine—Somnolence—Fluorouracil—skin cancer	0.000425	0.00245	CcSEcCtD
Loratadine—Gastrointestinal pain—Temozolomide—skin cancer	0.000424	0.00245	CcSEcCtD
Loratadine—Dyspepsia—Fluorouracil—skin cancer	0.000421	0.00243	CcSEcCtD
Loratadine—Dysgeusia—Docetaxel—skin cancer	0.000414	0.00239	CcSEcCtD
Loratadine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000413	0.00238	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—skin cancer	0.000411	0.00238	CcSEcCtD
Loratadine—Body temperature increased—Temozolomide—skin cancer	0.00041	0.00237	CcSEcCtD
Loratadine—Abdominal pain—Temozolomide—skin cancer	0.00041	0.00237	CcSEcCtD
Loratadine—Pain—Fluorouracil—skin cancer	0.000409	0.00236	CcSEcCtD
Loratadine—Feeling abnormal—Fluorouracil—skin cancer	0.000394	0.00227	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—skin cancer	0.000392	0.00227	CcSEcCtD
Loratadine—Vomiting—Bleomycin—skin cancer	0.000391	0.00226	CcSEcCtD
Loratadine—Rash—Bleomycin—skin cancer	0.000388	0.00224	CcSEcCtD
Loratadine—Dermatitis—Bleomycin—skin cancer	0.000387	0.00224	CcSEcCtD
Loratadine—Syncope—Docetaxel—skin cancer	0.000379	0.00219	CcSEcCtD
Loratadine—Body temperature increased—Fluorouracil—skin cancer	0.000378	0.00218	CcSEcCtD
Loratadine—Palpitations—Docetaxel—skin cancer	0.000373	0.00216	CcSEcCtD
Loratadine—Asthenia—Temozolomide—skin cancer	0.000372	0.00215	CcSEcCtD
Loratadine—Loss of consciousness—Docetaxel—skin cancer	0.000371	0.00215	CcSEcCtD
Loratadine—Cough—Docetaxel—skin cancer	0.000369	0.00213	CcSEcCtD
Loratadine—Nausea—Bleomycin—skin cancer	0.000365	0.00211	CcSEcCtD
Loratadine—Hypertension—Docetaxel—skin cancer	0.000365	0.00211	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—skin cancer	0.000365	0.00211	CcSEcCtD
Loratadine—Rash—Dactinomycin—skin cancer	0.000362	0.00209	CcSEcCtD
Loratadine—Chest pain—Docetaxel—skin cancer	0.00036	0.00208	CcSEcCtD
Loratadine—Myalgia—Docetaxel—skin cancer	0.00036	0.00208	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000357	0.00206	CcSEcCtD
Loratadine—Diarrhoea—Temozolomide—skin cancer	0.000355	0.00205	CcSEcCtD
Loratadine—Dry mouth—Docetaxel—skin cancer	0.000352	0.00203	CcSEcCtD
Loratadine—Anaphylactic shock—Docetaxel—skin cancer	0.000345	0.00199	CcSEcCtD
Loratadine—Dizziness—Temozolomide—skin cancer	0.000343	0.00198	CcSEcCtD
Loratadine—Nausea—Dactinomycin—skin cancer	0.000341	0.00197	CcSEcCtD
Loratadine—Shock—Docetaxel—skin cancer	0.000339	0.00196	CcSEcCtD
Loratadine—Nervous system disorder—Docetaxel—skin cancer	0.000338	0.00195	CcSEcCtD
Loratadine—Tachycardia—Docetaxel—skin cancer	0.000337	0.00194	CcSEcCtD
Loratadine—Skin disorder—Docetaxel—skin cancer	0.000335	0.00194	CcSEcCtD
Loratadine—Vomiting—Temozolomide—skin cancer	0.00033	0.00191	CcSEcCtD
Loratadine—Rash—Temozolomide—skin cancer	0.000327	0.00189	CcSEcCtD
Loratadine—Diarrhoea—Fluorouracil—skin cancer	0.000327	0.00189	CcSEcCtD
Loratadine—Dermatitis—Temozolomide—skin cancer	0.000327	0.00189	CcSEcCtD
Loratadine—Headache—Temozolomide—skin cancer	0.000325	0.00188	CcSEcCtD
Loratadine—Hypotension—Docetaxel—skin cancer	0.000322	0.00186	CcSEcCtD
Loratadine—Dizziness—Fluorouracil—skin cancer	0.000316	0.00183	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000314	0.00182	CcSEcCtD
Loratadine—Insomnia—Docetaxel—skin cancer	0.000312	0.0018	CcSEcCtD
Loratadine—Paraesthesia—Docetaxel—skin cancer	0.00031	0.00179	CcSEcCtD
Loratadine—Nausea—Temozolomide—skin cancer	0.000308	0.00178	CcSEcCtD
Loratadine—Somnolence—Docetaxel—skin cancer	0.000307	0.00177	CcSEcCtD
Loratadine—Vomiting—Fluorouracil—skin cancer	0.000304	0.00176	CcSEcCtD
Loratadine—Dyspepsia—Docetaxel—skin cancer	0.000304	0.00175	CcSEcCtD
Loratadine—Rash—Fluorouracil—skin cancer	0.000301	0.00174	CcSEcCtD
Loratadine—Dermatitis—Fluorouracil—skin cancer	0.000301	0.00174	CcSEcCtD
Loratadine—Headache—Fluorouracil—skin cancer	0.000299	0.00173	CcSEcCtD
Loratadine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000298	0.00172	CcSEcCtD
Loratadine—Fatigue—Docetaxel—skin cancer	0.000297	0.00172	CcSEcCtD
Loratadine—Pain—Docetaxel—skin cancer	0.000295	0.0017	CcSEcCtD
Loratadine—Constipation—Docetaxel—skin cancer	0.000295	0.0017	CcSEcCtD
Loratadine—Feeling abnormal—Docetaxel—skin cancer	0.000284	0.00164	CcSEcCtD
Loratadine—Nausea—Fluorouracil—skin cancer	0.000284	0.00164	CcSEcCtD
Loratadine—Gastrointestinal pain—Docetaxel—skin cancer	0.000282	0.00163	CcSEcCtD
Loratadine—Abdominal pain—Docetaxel—skin cancer	0.000273	0.00158	CcSEcCtD
Loratadine—Body temperature increased—Docetaxel—skin cancer	0.000273	0.00158	CcSEcCtD
Loratadine—Asthenia—Docetaxel—skin cancer	0.000247	0.00143	CcSEcCtD
Loratadine—Diarrhoea—Docetaxel—skin cancer	0.000236	0.00136	CcSEcCtD
Loratadine—Dizziness—Docetaxel—skin cancer	0.000228	0.00132	CcSEcCtD
Loratadine—Vomiting—Docetaxel—skin cancer	0.000219	0.00127	CcSEcCtD
Loratadine—Rash—Docetaxel—skin cancer	0.000217	0.00126	CcSEcCtD
Loratadine—Dermatitis—Docetaxel—skin cancer	0.000217	0.00126	CcSEcCtD
Loratadine—Headache—Docetaxel—skin cancer	0.000216	0.00125	CcSEcCtD
Loratadine—Nausea—Docetaxel—skin cancer	0.000205	0.00118	CcSEcCtD
